GetTopicDetailResponse(id=78d88e07670, topicName=苯達莫司汀-利妥昔單抗, introduction=苯達莫司汀-利妥昔單抗, content=null, image=null, comments=3, allHits=1333, url=https://h5.medsci.cn/topic?id=87076, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=81041, tagList=[TagDto(tagId=81041, tagName=苯達莫司汀-利妥昔單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2263770, encodeId=6eb52263e700e, content=<a href='/topic/show?id=c4a844521e5' target=_blank style='color:#2F92EE;'>#套細胞淋巴瘤#</a> <a href='/topic/show?id=78d88e07670' target=_blank style='color:#2F92EE;'>#苯達莫司汀-利妥昔單抗#</a> <a href='/topic/show?id=f8ed113380c7' target=_blank style='color:#2F92EE;'>#阿卡替尼#</a>, objectTitle=JCO | 阿卡替尼聯(lián)合利妥昔單抗：優(yōu)化MCL患者的一線治療方案, objectType=article, longId=874975, objectId=b86d8e4975b6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250506/1746538634108_6145188.png, objectUrl=/article/show_article.do?id=b86d8e4975b6, replyNumber=0, likeNumber=28, createdTime=2025-05-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=b86d8e4975b6, moduleTitle=JCO | 阿卡替尼聯(lián)合利妥昔單抗：優(yōu)化MCL患者的一線治療方案, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b86d8e4975b6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1600735, encodeId=f7fc1600e35e6, content=<a href='/topic/show?id=78d88e07670' target=_blank style='color:#2F92EE;'>#苯達莫司汀-利妥昔單抗#</a>, objectTitle=Lancet Oncol：Zanubrutinib vs 苯達莫司汀-利妥昔單抗治療初治慢性淋巴細胞白血病和小淋巴細胞淋巴瘤, objectType=article, longId=731945, objectId=fdbde3194517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdbde3194517, replyNumber=0, likeNumber=120, createdTime=2022-07-11, rootId=0, userName=Homburg, userId=198f18794112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdbde3194517, moduleTitle=Lancet Oncol：Zanubrutinib vs 苯達莫司汀-利妥昔單抗治療初治慢性淋巴細胞白血病和小淋巴細胞淋巴瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fdbde3194517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600734, encodeId=022c1600e3467, content=<a href='/topic/show?id=78d88e07670' target=_blank style='color:#2F92EE;'>#苯達莫司汀-利妥昔單抗#</a>, objectTitle=ANN ONCOL：Venetoclax聯(lián)合苯達莫司汀-利妥昔單抗治療復(fù)發(fā)/難治性非霍奇金淋巴瘤, objectType=article, longId=149945, objectId=ad0014994583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad0014994583, replyNumber=0, likeNumber=93, createdTime=2018-09-30, rootId=0, userName=Homburg, userId=198f18794112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad0014994583, moduleTitle=ANN ONCOL：Venetoclax聯(lián)合苯達莫司汀-利妥昔單抗治療復(fù)發(fā)/難治性非霍奇金淋巴瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ad0014994583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600733, encodeId=defc1600e33eb, content=<a href='/topic/show?id=78d88e07670' target=_blank style='color:#2F92EE;'>#苯達莫司汀-利妥昔單抗#</a>, objectTitle=苯達莫司汀-利妥昔單抗可使惰性淋巴瘤無進展生存期翻番, objectType=article, longId=6773, objectId=4b166e73df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b166e73df, replyNumber=0, likeNumber=130, createdTime=2012-06-07, rootId=0, userName=Homburg, userId=198f18794112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b166e73df, moduleTitle=苯達莫司汀-利妥昔單抗可使惰性淋巴瘤無進展生存期翻番, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4b166e73df)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
